Home>
US Stocks>
Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc (JAZZ) live share price

Jazz Pharmaceuticals Plc share price in USD $121.59 & INR ₹10,279.10

$121.59

▲

-1.05

(-0.86%)

View live Jazz Pharmaceuticals Plc share price in Dollar and Rupees. Guide to invest in Jazz Pharmaceuticals Plc from India. Also see the sentimental analysis on Indian investors investing in Jazz Pharmaceuticals Plc. Get details on the Indian mutual funds that are investing in Jazz Pharmaceuticals Plc. Get Analyst recommendations and forecasts along with all the Jazz Pharmaceuticals Plc's financials.

Jazz Pharmaceuticals Plc share price movements

$120.55
$122.69
$121.59
0.86%
Downside
Day's Volatility :1.74%
Upside
0.9%
$99.06
$134.17
$121.59
18.53%
Downside
52 Weeks Volatility :26.17%
Upside
9.38%

Jazz Pharmaceuticals Plc Returns

Period	Jazz Pharmaceuticals Plc	Sector (Health Care)	Index (Russel 2000)
3 Months	11.22%	-6.2%	0.0%
6 Months	14.99%	2.6%	0.0%
1 Year	0.12%	11.8%	0.0%
3 Years	1.11%	13.8%	-17.6%

Jazz Pharmaceuticals Plc Key Statistics

in dollars & INR

Market Capitalization	$7.4B
Revenue TTM	$4.0B
EBITDA	$1.5B
Earnings Per Share (EPS)	$7.06
PE Ratio	17.37
Profit Margin	11.6%
Quarterly Earnings Growth YOY	0.6%
Return On Equity TTM	12.09%

How to invest in Jazz Pharmaceuticals Plc from India?

It is very easy for Indian residents to invest directly in Jazz Pharmaceuticals Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Jazz Pharmaceuticals Plc stock in both rupees (INR) and dollars (USD). Search for Jazz Pharmaceuticals Plc or JAZZ on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Jazz Pharmaceuticals Plc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Jazz Pharmaceuticals Plc shares which would translate to 0.007 fractional shares of Jazz Pharmaceuticals Plc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Jazz Pharmaceuticals Plc

67%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Jazz Pharmaceuticals Plc on INDmoney from India has grown in the last 30 days as on Dec 2, 2024. 67% more investors are searching Jazz Pharmaceuticals Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Jazz Pharmaceuticals Plc

BlackRock Inc
10.17%
Vanguard Group Inc
10.10%
LSV Asset Management
4.13%
State Street Corp
3.34%
Pacer Advisors, INC.
3.01%
Capital World Investors
3.01%

Analyst Recommendation on Jazz Pharmaceuticals Plc

Buy

80%Buy

20%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Jazz Pharmaceuticals Plc(by analysts ranked 0 to 5 stars)

Based on 25 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Jazz Pharmaceuticals Plc

What analysts predicted

Upside of 46.0%

Current:

$121.59

Target:

$177.53

Insights on Jazz Pharmaceuticals Plc

Increasing Revenue
Revenue is up for the last 3 quarters, 901.98M → 1.05B (in $), with an average increase of 7.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -14.61M → 215.05M (in $), with an average increase of 65.1% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 45.5%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 40.6% return, outperforming this stock by 40.2%

Jazz Pharmaceuticals Plc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.9B	↑ 16.82%
Net Income	$447.1M	↓ 8.35%
Net Profit Margin	23.64%	↓ 6.5%

	FY19	Y/Y Change
Revenue	$2.2B	↑ 14.32%
Net Income	$523.4M	↑ 17.06%
Net Profit Margin	24.21%	↑ 0.57%

	FY20	Y/Y Change
Revenue	$2.4B	↑ 9.34%
Net Income	$238.6M	↓ 54.41%
Net Profit Margin	10.1%	↓ 14.11%

	FY21	Y/Y Change
Revenue	$3.1B	↑ 30.91%
Net Income	$-329.0M	↓ 237.86%
Net Profit Margin	-10.63%	↓ 20.73%

	FY22	Y/Y Change
Revenue	$3.7B	↑ 18.26%
Net Income	$-214.1M	↓ 34.9%
Net Profit Margin	-5.85%	↑ 4.78%

	FY23	Y/Y Change
Revenue	$3.8B	↑ 4.78%
Net Income	$414.8M	↓ 293.72%
Net Profit Margin	10.82%	↑ 16.67%

	Q2 FY23	Q/Q Change
Revenue	$957.3M	↑ 7.22%
Net Income	$104.4M	↑ 50.44%
Net Profit Margin	10.91%	↑ 3.13%

	Q3 FY23	Q/Q Change
Revenue	$972.1M	↑ 1.55%
Net Income	$146.8M	↑ 40.58%
Net Profit Margin	15.1%	↑ 4.19%

	Q4 FY23	Q/Q Change
Revenue	$1.0B	↑ 4.09%
Net Income	$94.2M	↓ 35.87%
Net Profit Margin	9.3%	↓ 5.8%

	Q1 FY24	Q/Q Change
Revenue	$902.0M	↓ 10.87%
Net Income	$-14.6M	↓ 115.53%
Net Profit Margin	-1.62%	↓ 10.92%

	Q2 FY24	Q/Q Change
Revenue	$1.0B	↑ 13.51%
Net Income	$168.6M	↓ 1253.15%
Net Profit Margin	16.46%	↑ 18.08%

	Q3 FY24	Q/Q Change
Revenue	$1.1B	↑ 3.04%
Net Income	$215.1M	↑ 27.58%
Net Profit Margin	20.38%	↑ 3.92%

	FY18	Y/Y Change
Total Assets	$5.2B	↑ 1.56%
Total Liabilities	$2.4B	↑ 1.47%

	FY19	Y/Y Change
Total Assets	$5.5B	↑ 6.45%
Total Liabilities	$2.4B	↓ 0.74%

	FY20	Y/Y Change
Total Assets	$6.5B	↑ 18.0%
Total Liabilities	$2.9B	↑ 18.46%

	FY21	Y/Y Change
Total Assets	$12.3B	↑ 88.17%
Total Liabilities	$8.3B	↑ 189.74%

	FY22	Y/Y Change
Total Assets	$10.8B	↓ 11.9%
Total Liabilities	$7.7B	↓ 7.01%

	FY23	Y/Y Change
Total Assets	$11.4B	↑ 5.15%
Total Liabilities	$7.7B	↓ 1.2%

	Q2 FY23	Q/Q Change
Total Assets	$11.3B	↑ 1.93%
Total Liabilities	$7.7B	↑ 0.3%

	Q3 FY23	Q/Q Change
Total Assets	$11.2B	↓ 0.5%
Total Liabilities	$7.7B	↓ 0.26%

	Q4 FY23	Q/Q Change
Total Assets	$11.4B	↑ 1.69%
Total Liabilities	$7.7B	↓ 0.76%

	Q1 FY24	Q/Q Change
Total Assets	$11.3B	↓ 0.58%
Total Liabilities	$7.6B	↓ 0.34%

	Q2 FY24	Q/Q Change
Total Assets	$11.4B	↑ 0.31%
Total Liabilities	$7.6B	↓ 0.41%

	Q3 FY24	Q/Q Change
Total Assets	$12.3B	↑ 7.87%
Total Liabilities	$8.1B	↑ 6.39%

	FY18	Y/Y Change
Operating Cash Flow	$798.9M	↑ 15.27%
Investing Cash Flow	$-394.5M	↑ 46.68%
Financing Cash Flow	$-479.1M	↑ 17.11%

	FY19	Y/Y Change
Operating Cash Flow	$776.4M	↓ 2.82%
Investing Cash Flow	$-155.3M	↓ 60.63%
Financing Cash Flow	$-293.7M	↓ 38.69%

	FY20	Y/Y Change
Operating Cash Flow	$899.6M	↑ 15.87%
Investing Cash Flow	$-1.0B	↑ 548.85%
Financing Cash Flow	$528.1M	↓ 279.77%

	FY21	Y/Y Change
Operating Cash Flow	$778.5M	↓ 13.47%
Investing Cash Flow	$-5.2B	↑ 417.25%
Financing Cash Flow	$4.0B	↑ 651.89%

	FY22	Y/Y Change
Operating Cash Flow	$1.3B	↑ 63.39%
Investing Cash Flow	$-446.2M	↓ 91.44%
Financing Cash Flow	$-529.5M	↓ 113.34%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$296.8M	↓ 7.47%
Investing Cash Flow	$-85.7M	↑ 1678.08%
Financing Cash Flow	$-96.7M	↑ 224.52%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$307.2M	↑ 3.51%
Investing Cash Flow	$-174.3M	↑ 103.29%
Financing Cash Flow	$-78.5M	↓ 18.8%

Jazz Pharmaceuticals Plc Technicals Summary

Sell

Neutral

Buy

Jazz Pharmaceuticals Plc is currently in a neutral trading position according to technical analysis indicators.

Jazz Pharmaceuticals Plc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Jazz Pharmaceuticals Plc	10.09%	14.99%	0.12%	1.11%	-17.93%
Regeneron Pharmaceuticals, Inc.	-11.07%	-24.18%	-8.88%	18.12%	102.78%
Biontech Se	6.2%	15.09%	18.5%	-65.59%	454.0%
Alnylam Pharmaceuticals, Inc.	-7.61%	68.21%	46.39%	47.68%	107.47%
Vertex Pharmaceuticals Incorporated	-0.63%	-0.44%	33.51%	129.69%	109.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Jazz Pharmaceuticals Plc	17.37	17.37	0.91	20.18	0.12	0.05	NA	69.01
Regeneron Pharmaceuticals, Inc.	18.66	18.66	1.12	44.91	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.22	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Jazz Pharmaceuticals Plc	Buy	$7.4B	-17.93%	17.37	11.6%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	102.78%	18.66	33.61%
Biontech Se	Buy	$28.9B	454.0%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	107.47%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$119.6B	109.07%	32.84	-4.51%

About Jazz Pharmaceuticals Plc

jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni

Organization	Jazz Pharmaceuticals Plc
Employees	2800
CEO	Mr. Bruce C. Cozadd
Industry	Health Technology

Important FAQs about investing in Jazz Pharmaceuticals Plc from India :

What is Jazz Pharmaceuticals Plc share price today?

Jazz Pharmaceuticals Plc (JAZZ) share price today is $121.59.

Can Indians buy Jazz Pharmaceuticals Plc shares?

Yes, Indians can invest in the Jazz Pharmaceuticals Plc (JAZZ) from India.

With INDmoney, you can buy Jazz Pharmaceuticals Plc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Jazz Pharmaceuticals Plc at zero transaction cost.

How can I buy Jazz Pharmaceuticals Plc shares from India?

It is very easy to buy Jazz Pharmaceuticals Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Jazz Pharmaceuticals Plc be purchased?

Yes, you can buy fractional shares of Jazz Pharmaceuticals Plc with INDmoney app.

What are the documents required to start investing in Jazz Pharmaceuticals Plc stocks?

To start investing in Jazz Pharmaceuticals Plc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.